T1	Participants 550 608	pediatric subjects with autistic disorder, aged 6-17 years
T2	Participants 913 937	316 randomized subjects,
T3	Participants 610 710	Subjects were stratified by PAE; adverse events (AEs), and changes in weight, and metabolic measures
